Kutatási jelek – Signal Engine

• MSK Head and Neck Cancer: Thyroid Cancer Research Update | Memorial Sloan Kettering Cancer Center — Thyroid cancer
• Early‑Onset Colorectal Cancer: From Genetic Discovery to Clinical Innovation — Colorectal cancer
• Scientists uncover immune cells that help prostate cancer resist treatment and a way to stop them — Prostate cancer
• New discovery remarkably improves immunotherapy in bladder cancer and beyond — Bladder cancer
• Adenoid cystic carcinoma (ACC) — Adenoid cystic carcinoma
• Bosutinib Shows Promise in Treating Children with Newly Diagnosed Ph+ CML — Chronic myeloid leukemia
• Adding Durvalumab to Usual Chemotherapy for People with Early-Stage Breast Cancer and MammaPrint High 2 Test Results — Breast cancer
• MRD-Guided Ibrutinib Plus Venetoclax Therapy for CLL — Chronic lymphocytic leukemia
• Clinical Trial Highlights - Leiomyoarcoma.info — Leiomyosarcoma
• ANHL1931: Nivolumab and Chemoimmunotherapy for Lymphoma — Lymphoma
• CAN MANTLE CELL LYMPHOMA BE CURED? INSIGHTS FROM 25 YEARS OF... — Mantle cell lymphoma
• Webinar | Intermediate Risk Bladder Cancer: Understanding Your Treatment Options — Bladder cancer
• Unmet Needs in Inoperable Locally Recurrent or Metastatic SCAC — Anal squamous cell carcinoma
• Tagitanlimab Improves Upon Chemo in Recurrent, Metastatic Nasopharyngeal Cancer — Melanoma
• Research GISTs – GIST Cancer UK — Gastrointestinal stromal tumor
• Combination of Acimtamig and AlloNK Effective in R/R Classical Hodgkin Lymphoma — Hodgkin lymphoma
• New Standard-of-Care Emerges for Multiple Myeloma — Multiple myeloma
• Leiomyosarcoma — Leiomyosarcoma
• New Understanding of a Decades-Old Bladder Cancer Treatment Could Help Improve Immunotherapies More Broadly — Bladder cancer
• Current and Future Directions of Immunotherapies in Multiple Myeloma — Multiple myeloma